Importance of bone densitometry in cardiovascular risk prediction


Authors: Killinger Zdenko;  Čierny Daniel;  Brázdilová Kristina;  Kužma Martin;  Jackuliak Peter;  Payer Juraj
Authors‘ workplace: V. interná klinika LF UK a UNB, Nemocnica Ružinov, Bratislava
Published in: Clinical Osteology 2019; 24(1): 19-22
Category:

Overview

Cardiovascular diseases (CVD) are the most common causes of mortality and morbidity in Slovakia, and therefore early assessment of cardiovascular risk profile for asymptomatic subjects remains one of the major medical problems. Recently, in addition to assessing standard cardiovascular risk factors (CV), attention on to the evaluation of abdominal aortic calcifications is focused. Several studies have shown incidence of aortic calcification as an independent risk factor of developing CV mortality, including ischemic stroke. To quantify aortic calcifications several scoring systems have been developed and many authors have shown that high aortic calcification index positively correlates with CV risk, independently of the presence of classical CV risk factors. Increased interest in their evaluation was also enhanced by the broadening of methods used for identifying calcifications in vessels such as USG, X-ray and CT, but also the use of a bone densitometry (DXA), which became a widely available method. To detect aortic calcifications by DXA a lateral projection could be used, similarly to detection of asymptomatic vertebral fractures. An indisputable advantage of the method is the fact that many patients in the elderly are undergoing this exa­mination and generally they do not have assessed a CV risk profile. In addition, the relationship between osteoporosis, metabolic syndrome and cardiovascular morbidity has been revealed in recent years. Therefore, physicians managing osteoporosis could contribute to early detection of “asymptomatic” patients with increased CV risk and initiate preventive or therapeutic measures in subsequent collaboration with other specialists to reduce CV morbi­dity and mortality. In this review, we are describing possibilities to use DXA for assessment of aortic calcifications and its potential to prevent CVD among patients with osteoporosis.

Keywords:

DXA – cardiovascular risk – DXA


Sources
  1. Mönckeberg JG. Über die reine Mediaverkalkung der Extremitätenarterien und ihr Verhalten zur Arteriosklerose. Virchows Arch Pathol Anat Physiol Klin Med 1903: 171: 141–167.
  2. Abedin M, Tintut Y, Demer LL. Vascular calcification: mechanisms and clinical Ramifications. Arterioscler Thromb Vasc Biol 2004; 24(7): 1161–1170. Dostupné z DOI: <http://dx.doi.org/10.1161/01.ATV.0000133194.94939.42>.
  3. London GM, Guerin AP, Marchais SJ et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18(9): 1731–1740. Dostupné z DOI: <http://dx.doi.org/10.1093/ndt/gfg414>.
  4. Micheletti P, Fishbein GA, Currier JS et al. Monckeberg sclerosis revisited: a clarification of the histologic definition of Monckeberg sclerosis. Arch Pathol Lab Med 2008; 132(1): 43–47. Dostupné z DOI: <http://dx.doi.org/10.1043/1543–2165(2008)132[43:MSRACO]2.0.CO;2>.
  5. Amann K. Media calcification and intima calcification are distinct entities in chronic kidney disease. Clin J Am Soc Nephrol 2008; 3(6): 1599–1605. Dostupné z DOI: <http://dx.doi.org/10.2215/CJN.02120508>.
  6. Bostrom KI. Where do we stand on vascular calcification? Vascul Pharmacol 2016; 84: 8–14. Dostupné z DOI: <http://dx.doi.org/10.1016/j.vph.2016.05.014>.
  7. Touw WA, Ueland T, Bollerslev J et al. Association of circulating Wnt antagonists with severe abdominal aortic calcification in elderly women. J Endocr Soc 2017; 1(1): 26–38. Dostupné z DOI: <http://dx.doi.org/10.1210/js.2016–1040>.
  8. Collin-Osdoby P. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Circ Res 2004; 95(11):1046–1057. Dostupné z DOI: <http://dx.doi.org/10.1161/01.RES.0000149165.99974.12>.
  9. Shanahan CM, Crouthamel MH, Kapustin A et al. Arterial calcification inchronic kidney disease: key roles for calcium and phosphate. Circ Res 2011; 109(6): 697–711. Dostupné z DOI: <http://dx.doi.org/10.1161/CIRCRESAHA.110.234914>.
  10. Hruska KA, Mathew S, Saab G. Bone morphogenetic proteins in vascular calcification. Circ Res 2005; 97(2): 105–114. Dostupné z DOI: <http://dx.doi.org/10.1161/01.RES.00000175571.53833.6c>.
  11. Jahnen-Dechent W, Heiss A, Schafer C et al. Fetuin-A regulation of calcified matrix metabolism. Circ Res 2011; 108(12): 1494–1509. Dostupné z DOI: <http://dx.doi.org/10.1161/CIRCRESAHA.110.234260>.
  12. Thompson B, Towler DA. Arterial calcification and bone physiology: role of the bone-vascular axis. Nat Rev Endocrinol 2012; 8(9): 529–543. Dostupné z DOI: <http://dx.doi.org/10.1038/nrendo.2012.36>.
  13. Szulc P. Abdominal aortic calcification: a reappraisal of epidemiological and patho-physiological data. Bone 2016; 84: 25–37. Dostupné z DOI: <http://dx.doi.org/10.1016/j.bone.2015.12.004>.
  14. Evrard S, Delanaye P, Kamel S et al. Calcifications, Vascular calcification: from pathophysiology to biomarkers. Clin Chim Acta 2015; 438: 401–414. Dostupné z DOI: <http://dx.doi.org/10.1016/j.cca.2014.08.034>.
  15. Kauppila LI, Polak JF, Cupples LA et al. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 1997; 132(2): 245–250.
  16. Stary HC, Chandler AB, Dinsmore BE et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Throm Vasc Biol 1995; 15(9): 1512–1531.
  17. Hollander M, Hak AE, Koudstaal PJ et al. Comparison between measures of atherosclerosis and risk of stroke: the Rotterdam study. Stroke 2003; 34(10): 2367–2372. Dostupné z DOI: <http://dx.doi.org/10.1161/01.STR.0000091393.32060.0E>.
  18. van der Meer IM, Bots ML, Hofman A et al. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam study. Circulation 2004; 109(9): 1089–1094. Dostupné z DOI: <http://dx.doi.org/10.1161/01.CIR.0000120708.59903.1B>.
  19. Schousboe JT, Wilson KE, Kiel DP. Detection of abdominal aortic calcification with lateral spine imaging using DXA. J Clin Densitom 2006; 9(3): 302–308. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jocd.2006.05.007>.
  20. Schousboe JT, Lewis JR, Kiel DP. Abdominal aortic calcification on dual-energy X-ray absorptiometry: Methods of assessment and clinical significance. Bone 2017; 104: 91–100. Dostupné z DOI: <http://dx.doi.org/10.1016/j.bone.2017.01.025>.
  21. Schousboe JT, Wilson KE, Hangartner TN. Detection of aortic calcification during vertebral fracture assessment (VFA) compared to digital radiography. PLoS One 2007; 2(8): e715. Dostupné z DOI: <http://dx.doi.org/10.1371/journal.pone.0000715>.
  22. Setiawati R, Di Chio F, Rahardjo P et al. Quantitative assessment of abdominal aortic calcifications using lateral lumbar radiograph, Dual-energy X-ray absorptiometry, and quantitative computed tomography of the spine. J Clin Densitom 2016; 19(2): 242–249. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jocd.2015.01.007>.
  23. Golestani R, Tio R, Zeebregts CJ et al. Abdominal aortic calcification detected by dual X-ray absorptiometry: a strong predictor for cardiovascular events, Ann Med 2010; 42(7): 539–545. Dostupné z DOI: <http://dx.doi.ori.org/10.3109/07853890.2010.515604>.
  24. Bazzocchi A, Ciccarese F, Diano D et al. Dual-energy X-ray absorptiometry in the evaluation of abdominal aortic calcifications. J Clin Densitom 2012; 15(2): 198–204. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jocd.2011.11.002>.
  25. Toussaint ND, Lau KK, Strauss BJ et al. Determination and validation of aortic calcification measurement from lateral bone densitometry in dialysis patients. Clin J Am Soc Nephrol 2009; 4(1): 119–127. Dostupné z DOI: <http://dx.doi.org/10.2215/CJN.03410708>.
  26. Toussaint ND, Lau KK, Strauss BJ et al. Using vertebral bone densitometry to determine aortic calcification in patients with chronic kidney disease. Nephrology (Carlton) 2010; 15(5): 575–583. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1440–1797.2010.01288.x>.
  27. Čierny D, Brázdilová K, Payer J et al. Detekcia aortálnych kalcifikátov pri hodnotení bočných denzitometrických skenov. AtheroRev 2018; 3(2): 134–136.
  28. Walsh CR, Cupples LR, Levy D et al. Abdominal aortic calcific deposits are associated with increased risk for congestive heart failure: the Framingham heart study. Am Heart J 2002; 144(4): 733–739.
  29. Il’yasova D, Colbert LH, Harris TB, et al. Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomark Prev 2005; 14(10): 2413–2418. Dostupné z DOI: <http://dx.doi.org/10.1158/1055–9965.EPI-05–0316>.
  30. Ishimura E, Okuno S, Kitatani K et al. C-reactive protein is a significant predictor of vascular calcification of both aorta and hand arteries. Semin Nephrol 2004; 24(5): 408–412.
  31. Doyle SL, Donohoe CL, Lysaght J et al. Visceral obesity, metabolic syndrome, insulin resistance and cancer. Proc Nutr Soc 2012; 71(1): 181–189. Dostupné z DOI: <http://dx.doi.org/10.1017/S002966511100320X>
Labels
Clinical biochemistry Paediatric gynaecology Paediatric radiology Paediatric rheumatology Endocrinology Gynaecology and obstetrics Internal medicine Orthopaedics General practitioner for adults Radiodiagnostics Rehabilitation Rheumatology Traumatology
Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

×